This content was created by Everyday Health Media on behalf of an advertiser.
More Information.
Content on this page was created by the Everyday Health Media team and is funded by an advertiser. The content conforms to Everyday Health Media’s editorial standards for accuracy, objectivity, and balance. The advertiser may select the specialty area but does not edit or approve the content.
Eye on Wet AMD
Fibrosis in Wet AMD: A Multifactorial Process
"By 2 to 10 years, over 40% of patients with neovascular AMD will develop sub-retinal fibrosis," says Sarju Patel, MD, MPH, MSc, and this is often accompanied by a host of other problems. In this video, he reviews current work aimed at limiting scarring and preserving vision. (2:51)
Q&A: Durga Borkar, MD, on Progression of Geographic Atrophy in Age-Related Macular Degeneration
Dr. Borkar, of Duke University School of Medicine, discusses a recent study she coauthored on the disease course of geographic atrophy.
Age-related Macular Degeneration and Central Serous Chorioretinopathy Have Overlapping Genetics
Using a meta-analysis and genome-wide association studies, 3 novel loci for central serous chorioretinopathy were recently identified, and 2 previously reported CSC loci were confirmed. Three loci were found to be associated with both CSC and age-related macular degeneration.
A Clearer Picture: The Interplay of Dyslipidemia and Age-Related Macular Degeneration
A meta-analysis revealed a significant association between age-related macular degeneration and systemic dyslipidemia, which varies across different AMD stages and subtypes. This underscores the heterogeneity of AMD and the need for more-precise classification criteria.
In AMD, is the Amsler Grid Test Actually Useful in Screening and Detection?
The findings about the diagnostic accuracy of the Amsler grid test for early detection of neovascular age-related macular degeneration suggest that the procedure will not replace regular ophthalmic exams.